Cargando…
Recent developments in receptor tyrosine kinases targeted anticancer therapy
Novel concepts and understanding of receptors lead to discoveries and optimization of many small molecules and antibodies as anti-cancerous drugs. Receptor tyrosine kinases (RTKs) are such a promising class of receptors under the investigation in past three decades. RTKs are one of the essential med...
Autores principales: | Raval, Samir H., Singh, Ratn D., Joshi, Dilip V., Patel, Hitesh B., Mody, Shailesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Veterinary World
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819356/ https://www.ncbi.nlm.nih.gov/pubmed/27051190 http://dx.doi.org/10.14202/vetworld.2016.80-90 |
Ejemplares similares
-
Receptor Tyrosine Kinase-Targeted Cancer Therapy
por: Yamaoka, Toshimitsu, et al.
Publicado: (2018) -
Receptor Tyrosine Kinases in Kidney Development
por: Song, Renfang, et al.
Publicado: (2011) -
Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies
por: Schoumacher, Marie, et al.
Publicado: (2017) -
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
por: Qin, Shuang, et al.
Publicado: (2019) -
Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer
por: Elferink, Lisa A., et al.
Publicado: (2011)